OPK
$1.19
OPKO Health, Inc.
Intraday
Recent News
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts
OPKO Health beats Q4 earnings and revenue estimates, but sales decline and gross margin narrows.
OPKO Health, Inc. Q4 2025 Earnings Call Summary
Moby summary of OPKO Health, Inc.'s Q4 2025 earnings call
OPKO Health Q4 Earnings Call Highlights
OPKO Health (NASDAQ:OPK) executives said the company exited 2025 with “tremendous momentum,” citing efforts to reposition its diagnostics business for a return to profitability, advance its ModeX therapeutic pipeline, use non-dilutive partnership funding to support R&D, and strengthen the balanc
OPKO Health Inc (OPK) Q4 2025 Earnings Call Highlights: Strategic Divestitures and Promising ...
Despite a challenging quarter, OPKO Health Inc (OPK) focuses on core strengths and strategic partnerships to drive future profitability.
OPKO Health (OPK) Q4 2025 Earnings Call Transcript
Phillip Frost, Chairman and Chief Executive Officer, will provide opening remarks. Elias Zerhouni, Vice Chairman and President, will then provide an overview of BioReference Health as well as OPKO Health, Inc.'s Therapeutics segment.